Biodexa Pharmaceuticals Financial Ratios for Analysis 2014-2024 | BDRX

Fifteen years of historical annual and quarterly financial ratios and margins for Biodexa Pharmaceuticals (BDRX).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2023202220212020201920182017201620152014
1.262.476.393.102.422.272.222.392.2311.17
0.060.130.060.010.220.050.150.030.030.03
0.100.200.070.040.310.070.190.050.040.05
100.00100.00100.00100.00100.00100.0087.8190.3794.91100.00
-2,103.41-1,277.83-1,210.73-6,717.20-1,679.23-609.65-231.35-441.80-939.49-6,335.67
-2,103.41-1,277.83-1,210.73-6,717.20-1,679.23-609.65-231.35-441.80-939.49-6,335.67
-2,029.13-1,228.76-1,141.00-6,362.39-1,488.58-534.83-197.66-378.90-885.89-6,130.57
-1,964.57-1,214.31-1,056.40-6,842.57-1,620.62-639.83-228.07-423.54-816.87-6,433.12
-1,858.01-1,095.28-944.64-6,469.10-1,496.29-775.54-211.42-291.23-734.47-5,784.71
0.040.130.040.030.020.090.150.120.020.00
------0.980.820.15-
0.360.380.340.200.240.591.711.790.370.12
1,0159671,0761,8401,5216172132049813,029
-151.33-242.13-52.24-330.29-46.72-61.26-46.33-44.10-21.54-21.63
-407.54-242.59-52.24-330.29-127.29-227.87-228.54-138.55-182.03-31.43
-67.15-138.57-42.28-226.03-29.58-50.71-32.63-35.57-15.77-19.46
-142.35-211.20-49.31-327.37-36.22-58.22-39.31-42.59-20.87-20.89
42.563.620.730.685.327.381.462.554.283.73
-233.91-8.83-0.51-1.40-2.26-5.87-0.65-0.98-1.35-1.99
-234.66-8.88-0.54-1.41-2.37-5.97-0.69-1.08-1.45-2.37

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2023-12-312023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312020-06-302019-12-312019-06-302018-12-312018-06-302017-12-312017-06-302016-12-312016-06-302015-12-312015-06-302014-12-31
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
-------------------
0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
-------------------